52 Week's Low
52 Week's High
Returns % | |
1 Month Return | -3.35 % |
3 Month Return | + 30.43 % |
1 Year Return | + 19.33 % |
Market Stats | |
Previous Close | ₹150.00 |
Open | ₹143.00 |
Volume | 1,200.00 |
Upper Circuit | - |
Lower Circuit | - |
Market Cap | ₹165.75Cr |
P/E Ratio | 35.63 |
PEG Ratio | -11.57 |
Market Cap | ₹165.75 Cr |
P/B Ratio | 0 |
EPS | 3.24 |
Dividend Yield | 0 |
Sector | Pharmaceuticals |
ROE | 32.04 |
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
---|---|---|---|---|---|---|
NA | ₹165.75 Cr | 4.84% | 0.67 | ₹3 Cr | ₹103 Cr | |
BUY | ₹28,124.56 Cr | 20.69% | 0.52 | NA | NA | |
NA | ₹327.69 Cr | 83.66% | 0.52 | NA | NA | |
NA | ₹16.34 Cr | 143.14% | 0.69 | NA | NA | |
NA | ₹478.43 Cr | 339.6% | 0.54 | ₹21 Cr | ₹144 Cr |
Organisation | Sotac Pharmaceuticals Ltd |
Headquarters | |
Industry | Pharmaceuticals |
E-voting on shares | Click here to vote |
Key events for Sotac Pharmaceuticals Ltd
Sotac Pharmaceuticals has a high P/E ratio of 39.7x, which may be unjustified despite strong recent earnings growth of 37%. Shareholders may face disappointment if the P/E falls to levels more in line with recent growth rates.
Sotac Pharmaceuticals Receives Order Worth Rs. 17.13 Crores - 26 Jun, 2024
Shares of Sotac Pharmaceuticals surged by 20% after receiving an order worth Rs. 17.13 crores from Rajasthan Medical Services Corporation Limited. The company's revenue increased by 35% and net profits magnified by 100% in FY23-24. Key customers include Cadila Pharma, Intas Pharma, and Eris Lifesciences. Promoters hold a stake of 72.85%, while FIIs hold 8.99% of the shares.
Sotac Pharmaceuticals' Financial Prospects Look Decent Despite Recent Stock Weakness - 05 Jun, 2024
Despite Sotac Pharmaceuticals' stock being down 33% over the past three months, its key financial indicators look decent. The company's ROE suggests that the stock could potentially rise in the long-term given more resilient long-term fundamentals.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
FII Holding Up
Foreign Institutions have increased holdings from 8.51% to 8.99% in Mar 2024 quarter
Promoter Holding Unchanged
Promoters holdings remained unchanged at 72.85% of holdings in Mar 2024 quarter
Retail Holding Down
Retail Investor have decreased holdings from 18.64% to 18.16% in Mar 2024 quarter
Profit Down
Netprofit is down for the last 2 quarters, 1.64 Cr → 1.45 Cr (in ₹), with an average decrease of 11.6% per quarter
Price Dip
In the last 1 month, SOTAC stock has moved down by -3.4%
Revenue Fall
Revenue is down for the last 2 quarters, 26.8 Cr → 25.5 Cr (in ₹), with an average decrease of 4.9% per quarter
Investors | Holdings % | FY Quarter | 3M change |
---|---|---|---|
Promoter Holdings | 72.85% | 0.00 | |
Foreign Institutions | 8.99% | 0.00 | |
Mutual Funds | 0% | 0.00 | |
Retail Investors | 18.16% | 0.00 | |
Others | 0% | 0.00 |
Sotac Pharmaceuticals Ltd in the last 5 years
Lowest (13.14x)
April 24, 2023
Today (35.63x)
September 5, 2024
Industry (58.97x)
September 5, 2024
Highest (44.90x)
July 16, 2024
Sotac Pharmaceuticals Ltd’s net profit jumped 34.26% since last year same period to ₹1.45Cr in the Q1 2024-2025. On a quarterly growth basis, Sotac Pharmaceuticals Ltd has generated -11.59% fall in its net profits since last 3-months.
Read More about Earnings ResultsBearish
Neutral
Bullish
Sotac Pharmaceuticals Ltd is currently in a Bearish trading position according to technical analysis indicators.
Sotac Pharmaceuticals Ltd (SOTAC) share price today is ₹143
Sotac Pharmaceuticals Ltd is listed on NSE
Sotac Pharmaceuticals Ltd is not listed on BSE
PE Ratio of Sotac Pharmaceuticals Ltd is 35.63
PE ratio = Sotac Pharmaceuticals Ltd Market price per share / Sotac Pharmaceuticals Ltd Earnings per share
Today’s traded volume of Sotac Pharmaceuticals Ltd(SOTAC) is 1,200.00.
Today’s market capitalisation of Sotac Pharmaceuticals Ltd(SOTAC) is ₹165.75Cr.
Sotac Pharmaceuticals Ltd(SOTAC | Price |
---|---|
52 Week High | ₹202.8 |
52 Week Low | ₹87.1 |
Sotac Pharmaceuticals Ltd(SOTAC) share price is ₹143. It is down -29.49% from its 52 Week High price of ₹202.8
Sotac Pharmaceuticals Ltd(SOTAC) share price is ₹143. It is up 64.18% from its 52 Week Low price of ₹87.1
Sotac Pharmaceuticals Ltd(SOTAC | Returns |
---|---|
1 Day Returns | -7% |
1 Month Returns | -3.35% |
3 Month Returns | 30.43% |
1 Year Returns | 19.33% |